Detalhe da pesquisa
1.
Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation.
Neurobiol Dis
; 194: 106475, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521093
2.
Mapping brain volume change across time in primary-progressive multiple sclerosis.
Neuroradiology
; 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609687
3.
Age-related blood transcriptional regulators affect disease progression in pediatric multiple sclerosis.
Neurobiol Dis
; 176: 105953, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493973
4.
Radiological Disease Activity in Secondary Progressive Multiple Sclerosis.
Eur Neurol
; 86(2): 116-120, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596291
5.
[TUMOR-LIKE EFFECT AS INITIAL PRESENTATION OF PEDIATRIC MULTIPLE SCLEROSIS].
Harefuah
; 162(10): 660-665, 2023 Dec.
Artigo
em Hebraico
| MEDLINE | ID: mdl-38126150
6.
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Mult Scler
; 28(9): 1424-1456, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196927
7.
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescents.
Pediatr Allergy Immunol
; 33(10): e13863, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282137
8.
Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple Sclerosis.
J Neuroophthalmol
; 42(1): e14-e21, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294657
9.
Cognitive Performance of Patients With Multiple Sclerosis and Optic Neuritis at Presentation.
J Neuroophthalmol
; 42(1): e8-e13, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870943
10.
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.
Mult Scler
; 27(6): 864-870, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33856242
11.
Central Neuropathic Pain in Multiple Sclerosis Is Associated with Impaired Innocuous Thermal Pathways and Neuronal Hyperexcitability.
Pain Med
; 22(10): 2311-2323, 2021 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33734398
12.
Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a.
J Neuroeng Rehabil
; 18(1): 175, 2021 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34924009
13.
Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood Components.
Isr Med Assoc J
; 23(1): 7-10, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443334
14.
RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice.
J Neuroinflammation
; 17(1): 313, 2020 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081798
15.
Cytokine prediction of mortality in COVID19 patients.
Cytokine
; 134: 155190, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673995
16.
Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy.
Mult Scler
; 25(13): 1746-1753, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381992
17.
Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.
Neuroradiology
; 60(2): 179-187, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29285552
18.
Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East.
BMC Neurol
; 17(1): 150, 2017 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784108
19.
Pilates exercise training vs. physical therapy for improving walking and balance in people with multiple sclerosis: a randomized controlled trial.
Clin Rehabil
; 31(3): 319-328, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26951348
20.
Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients.
J Neurovirol
; 22(6): 736-746, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27170332